Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1110022

registered interest
date	05/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	MMR Vaccine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the child MMR vaccination rates.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	241384
answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>Public Health England routinely monitors coverage for the national immunisation programme, including the measles, mumps and rubella (MMR) vaccine on a quarterly and annual basis.</p><p> </p><p>National coverage figures reported for the MMR first dose as measured at five years show coverage, which reached the World Health Organization recommended target level of 95% for the first-time last year, was 94.9% in England in 2017-18. Uptake of the second MMR dose by age five years in England was 87.2%. The 2017/18 data can be viewed at the following link:</p><p> </p><p><a href="https://files.digital.nhs.uk/55/D9C4C2/child-vacc-stat-eng-2017-18-report.pdf" target="_blank">https://files.digital.nhs.uk/55/D9C4C2/child-vacc-stat-eng-2017-18-report.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/04/2019 13:26:53 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1109775

registered interest
date	04/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will issue a response to Early Day Motion 1832, on legalisation of medical cannabis.
tabling member constituency	Glasgow North
tabling member printed	Patrick Grady
uin	241057
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Government is clear that the decision to prescribe a cannabis-based product for medicinal use should only be made where it is clinically appropriate and in the best interest of the patient. This will be subject to local National Health Service governance and funding arrangements for prescribing unlicensed medicines, and patients will not be able to be prescribed such products by their general practitioner – and would require referral to a specialist clinician on the basis of clinical need.</p><p>The evidence base for cannabis-based products for medicinal use is still developing. However, the changes to the law are designed to encourage further research and the National Institute for Health Research has issued two calls for research proposals to rapidly advance knowledge in this area and remains open to research proposals outside of these calls in this priority area.</p><p>Interim clinical guidance, issued by the Royal College of Physicians, British Paediatric Neurology Association and Association of British Neurologists is based on the best available international evidence and reflects clinical guidance that has been published in other jurisdictions. This guidance will be updated and replaced in October 2019 by that commissioned from the National Institute for Health and Care Excellence.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:40:03 answering member 4455 label Biography information for Seema Kennedy
tabling member	4432 label Biography information for Patrick Grady

1109797

registered interest
date	04/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 March 2019 to Question 230073 on Haemophilia, if he will place copies in the library of National Haemophilia Database data on the average number of bleeds people with (a) mild, (b) moderate and (c) severe (i) Haemophilia A and (ii) Haemophilia B had in the latest year for which data is available.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	240995
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Data on the average number of bleeds for people with severe haemophilia A and haemophilia B is shown in the following table.</p><table><tbody><tr><td rowspan="2"><p>Diagnosis</p></td><td rowspan="2"><p>Patients treated 2018<br> (number)</p></td><td colspan="3"><p>Bleed count 2018</p></td></tr><tr><td><p>Mean</p></td><td><p>Standard deviation</p></td><td><p>Median (interquartile range)</p></td></tr><tr><td><p>Severe Haemophilia A</p></td><td><p>1,553</p></td><td><p>4.1</p></td><td><p>8.2</p></td><td><p>1 (0 - 5)</p></td></tr><tr><td><p>Severe Haemophilia B</p></td><td><p>263</p></td><td><p>3.7</p></td><td><p>7.6</p></td><td><p>1 (0 - 4)</p></td></tr></tbody></table><p> </p><p>The National Haemophilia Database have very limited bleed-level data for patients with mild or moderate haemophilia, as these patients do not bleed frequently and therefore do not generally require home therapy. The non-severe patients using Haemtrack are skewed towards the severe end of moderate and anyone with zero bleeds is very unlikely to be reporting. For this reason, they have excluded non-severe patients from these results, as they would make the data unlikely to be robust.</p><p> </p><p>It should be noted that the following limitations apply to this data:</p><p> </p><p>1. The data is derived from patient-reported Haemtrack home therapy diary data.</p><p>2. The data is limited to patients who require home-therapy.</p><p>3. These results are prone to reporting bias since uncompliant patients and patients treated on-demand, treated only when they bleed, are under-represented in this sample. The data may therefore paint a slightly optimistic picture.</p><p>4. About 85-90% of clinically severely affected (less than 2% VIII/IX) patients are managed with regular prophylaxis to prevent bleeding. Prior to prophylaxis, patients treated on-demand bled between twice a week and once a fortnight and, as the figures show, the mean annualised bleed rate has been dramatically reduced to about four per year. However, our aim is for the patients to be bleed free, without which the joints will not be fully protected from bleeding.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:43:25 answering member 4455 label Biography information for Seema Kennedy
tabling member	1533 label Biography information for Dame Diana Johnson

1109799

registered interest
date	04/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 March 2019 to Question 230073 on Haemophilia, if he will place copies in the library of National Haemophilia Database data on the number and patients with (a) mild, (b) moderate and (c) severe (i) haemophilia A and (ii) haemophilia B by the number of bleeds they had in the most recent year for which data is available.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	240996
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The data on the number of patients with severe haemophilia A and haemophilia B by the number of bleeds is attached.</p><p> </p><p>The National Haemophilia Database (NHD) have very limited bleed-level data for patients with mild or moderate haemophilia since these patients do not bleed frequently and do not generally require home therapy. The non-severe patients using Haemtrack are skewed towards the severe end of moderate and anyone with zero bleeds is very unlikely to be reporting. For this reason, the NHD have excluded non-severe patients from this data, as it makes the data unlikely to be robust.</p><p> </p><p>It should be noted that the following limitations apply to this data:</p><ol><li>The data are derived from patient-reported Haemtrack home therapy diary data.</li><li>The data is limited to patients who require home-therapy.</li><li>These results are prone to reporting bias since uncompliant patients and patients treated on-demand, treated only when they bleed, are under-represented in this sample. The data may therefore paint a slightly optimistic picture.</li><li>About 85-90% of clinically severely affected (less than 2% VIII/IX) patients are managed with regular prophylaxis to prevent bleeding. Prior to prophylaxis, patients treated on-demand bled between twice a week and once a fortnight and, as the figures show, the mean annualised bleed rate has been dramatically reduced to about four per year. However, our aim is for the patients to be bleed free, without which the joints will not be fully protected from bleeding.</li></ol> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:50:49 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Pq240996 - bleeds for severe haemophilia.xlsx title PQ240996 attached information
tabling member	1533 label Biography information for Dame Diana Johnson

1109800

registered interest
date	04/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 March 2019 to Question 230073 on Haemophilia, if he will publish the number of patients with (a) mild, (b) moderate and (c) severe (i) haemophilia A and (ii) haemophilia B by (A) the number of bleeds they had in the most recent year for which data is available and (B) age groups (1) 0 to 18 and (2) over 18.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	240997
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The number of patients with severe haemophilia A and haemophilia B for 2018 by the number of bleeds they had and age groups 0 to 18 and over 18, is attached.</p><p> </p><p>The National Haemophilia Database (NHD) have very limited bleed-level data for patients with mild or moderate haemophilia who do not bleed frequently and do not generally require home therapy. The non-severe patients using Haemtrack are skewed towards the severe end of moderate and anyone with zero bleeds is very unlikely to be reporting. For this reason, the NHD have excluded non-severe patients from these results, as it makes the data unlikely to be robust.</p><p> </p><p>It should be noted that the following limitations apply to this data:</p><p>1. The data is derived from patient-reported Haemtrack home therapy diary data.</p><p>2. The data is limited to patients who require home-therapy.</p><p>3. These results are prone to reporting bias since uncompliant patients and patients treated on-demand, treated only when they bleed, are under-represented in this sample. The data may therefore paint a slightly optimistic picture.</p><p>4. About 85-90% of clinically severely affected (less than 2% VIII/IX) patients are managed with regular prophylaxis to prevent bleeding. Prior to prophylaxis, patients treated on-demand bled between twice a week and once a fortnight and, as the figures show, the mean annualised bleed rate has been dramatically reduced to about four per year. However, our aim is for the patients to be bleed free, without which the joints will not be fully protected from bleeding.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:59:08 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ240997 - data by age.xlsx title PQ240997 attached data
tabling member	1533 label Biography information for Dame Diana Johnson

1109819

registered interest
date	04/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tomography: Oxfordshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS England on the procurement of PET-CT scanning services in Oxfordshire.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	241088
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care meets with NHS England regularly to discuss a variety of topics.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:39:00 answering member 4455 label Biography information for Seema Kennedy
tabling member	4656 label Biography information for Layla Moran

1109333

registered interest
date	03/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the saving to the NHS of reducing the number of prescriptions for over-the-counter medicines.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	240507
answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>The Department has made no such assessment. From December 2017 to March 2018, NHS England carried out a public consultation on reducing prescribing of over-the-counter medicines for minor, short-term health concerns, ‘Conditions for which over the counter items should not routinely be prescribed in primary care: A consultation on guidance for CCGs’ which can be found at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/over-the-counter-items-not-routinely-prescribed/" target="_blank">https://www.engage.england.nhs.uk/consultation/over-the-counter-items-not-routinely-prescribed/</a></p><p> </p><p>At the end of March 2018, NHS England published guidance to enable savings of up to £100 million for frontline care each year by curbing prescriptions for ‘over the counter’ medicines. The guidance does not affect prescribing of over the counter items for longer term or more complex conditions, or where minor illnesses are symptomatic or a side effect of something more serious.</p><p> </p><p>We are informed by NHS England that in the 12 months to January 2019, the total National Health Service spend in England on over the counter items was £449.4 million. This was a saving on total spend of £25.9 million from the corresponding figure for the 12 months to January 2018, which was £475.3 million. This saving does not account for the potential impact to the NHS from a reduced number of general practitioner appointments, for which no assessment has been made.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:21:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	392 label Biography information for Sir Kevin Barron

1109355

registered interest
date	03/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle childhood obesity rates.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	240630
answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>I refer the hon. Member to the answer given by the former Parliamentary Under-Secretary of State for Public Health and Primary Care (Steve Brine MP) to the hon. Member for Cardiff Central (Jo Stevens MP) on 28 February 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-02-25/225540/" target="_blank">225540</a>.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:25:57 answering member 4455 label Biography information for Seema Kennedy
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1109438

registered interest
date	03/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure that the serious shortage protocols safeguard individuals who suffer from a condition, such as epilepsy, in which any change in medication could pose a serious risk to their health.
tabling member constituency	Ross, Skye and Lochaber
tabling member printed	Ian Blackford
uin	240571
answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>A serious shortage protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective. Any protocol would only be introduced if clinicians with expertise in the relevant area think it is appropriate. Pharmacists still have to use their professional discretion as to whether supplying against the protocol rather than the prescription is appropriate, or whether the patient needs to be referred back to their prescriber.</p><p> </p><p>As the explanatory memorandum of the amending Statutory Instrument acknowledges, protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, those types of protocols would not be suitable for treatments for epilepsy or treatments requiring biological products where the medicines that are prescribed need to be prescribed by brand for clinical reasons. In these cases, patients would always be referred back to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:24:32 answering member 4455 label Biography information for Seema Kennedy
tabling member	4390 label Biography information for Ian Blackford

1109485

registered interest
date	03/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Public Health: Enfield
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of (a) trends in the level of public health funding allocated to and (b) the correlation between those allocations and the effectiveness of the provision of public health services in the London borough of Enfield in each year since 2015.
tabling member constituency	Enfield North
tabling member printed	Joan Ryan
uin	240466
answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>The allocations of grant funding for public health to the London Borough of Enfield for each year since 2015/16 are shown in the following table:</p><table><tbody><tr><td><p>Year</p></td><td><p>Grant allocation (£000)</p></td></tr><tr><td><p>2015/16</p></td><td><p>£15,670*</p></td></tr><tr><td><p>2016/17</p></td><td><p>£17,708**</p></td></tr><tr><td><p>2017/18</p></td><td><p>£17,272</p></td></tr><tr><td><p>2018/19</p></td><td><p>£16,828</p></td></tr><tr><td><p>2019/20</p></td><td><p>£16,384</p></td></tr></tbody></table><p> </p><p>Notes:</p><p>*Allocation reflects the transfer to local authorities (LAs) in October 2015 of funding for services for children aged 0 – 5.</p><p>**Allocation reflects the full-year effect of the mid-2015/16 transfer.</p><p> </p><p>The grant is ring-fenced for use exclusively on public health, but within that LAs must decide their own priorities for action. LAs’ public health funding for 2020 onwards will be considered under the next spending review.</p><p> </p><p>We have made no specific assessment of any relationship between funding since 2015 and the effectiveness of services in Enfield. Public Health England (PHE) monitors and publishes data on trends in each LA in England for the wide range of indicators of public health set out in the Public Health Outcomes Framework. That framework can be found at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/public-health-outcomes-framework" target="_blank">https://www.gov.uk/government/collections/public-health-outcomes-framework</a></p><p> </p><p>In addition, the PHE ‘dashboard’ shows data for a smaller set of key indicators for all LAs, including Enfield, in ways that allow comparisons to be made. It is available at the following link:</p><p> </p><p><a href="https://fingertips.phe.org.uk/topic/public-health-dashboard#par/nn-1-E09000010/sim/nn-1-E09000010/are/E09000010/ati/102" target="_blank">https://fingertips.phe.org.uk/topic/public-health-dashboard#par/nn-1-E09000010/sim/nn-1-E09000010/are/E09000010/ati/102</a></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 240467 question first answered 08/04/2019 15:23:27 answering member 4455 label Biography information for Seema Kennedy
tabling member	166 label Biography information for Joan Ryan